Hello, I'm Nathan Brown
from the Institute of Cancer Research
and today I'm going to be talking to you
about computational methods
in ligand-based drug design
for medicinal chemistry.
So ligand-based drug design -
it's important to understand
what we do and how we achieve it.
So we use computational methods
to design, select and prioritise
synthetic chemistry targets
that will then contribute positively
to a medicinal chemistry project.
And how we do that is to,
starting from the top,
to identify potential substituents;
if we've got a core
scaffold of interest.
We then can enumerate libraries
in the computer, virtually.
From those libraries of possible
new chemical structures,
we can calculate predictions
in the computer using
empirical models and first principles models.
Then we prioritise compounds,
and then the most time-consuming part
is the chemical synthesis
and biological testing
of those target molecules.
Followed by data analysis
of the resulting data
and then we iterate around that
to design new, more potent,
and more effective drugs.
So an overview of this talk is,
we're going to cover
a number of different types
of molecular descriptors
including physicochemical properties
and structural fingerprints.
We'll then move onto concepts
of molecular similarity
and how they're used in virtual screening.
We'll then conclude with some aspects
of statistical learning,
in particular unsupervised learning
and supervised learning.